Liu, Y., Ananthakumar, A., Thompson, W., Myers, R., Kaddurah-Daouk, R., Dubois, L., … Voora, D. (2019). Metabolomic Profiling of Engineered Skeletal Myobundles Identifies a Plasma Biomarker for Statin Associated Musculoskeletal Symptoms (SAMS). In CIRCULATION (Vol. 140).

Liu, Yiling, Anandita Ananthakumar, Will Thompson, Rachel Myers, Rima Kaddurah-Daouk, Laura Dubois, George A. Truskey, and Deepak Voora. “Metabolomic Profiling of Engineered Skeletal Myobundles Identifies a Plasma Biomarker for Statin Associated Musculoskeletal Symptoms (SAMS).” In CIRCULATION, Vol. 140, 2019.

Liu Y, Ananthakumar A, Thompson W, Myers R, Kaddurah-Daouk R, Dubois L, et al. Metabolomic Profiling of Engineered Skeletal Myobundles Identifies a Plasma Biomarker for Statin Associated Musculoskeletal Symptoms (SAMS). In: CIRCULATION. 2019.

Liu, Yiling, et al. “Metabolomic Profiling of Engineered Skeletal Myobundles Identifies a Plasma Biomarker for Statin Associated Musculoskeletal Symptoms (SAMS).” CIRCULATION, vol. 140, 2019.

Liu Y, Ananthakumar A, Thompson W, Myers R, Kaddurah-Daouk R, Dubois L, Truskey GA, Voora D. Metabolomic Profiling of Engineered Skeletal Myobundles Identifies a Plasma Biomarker for Statin Associated Musculoskeletal Symptoms (SAMS). CIRCULATION. 2019.